Underuse of lipid-lowering therapies in 2021 in patients with established atherosclerotic cardiovascular disease (ASCVD): Results from the French nationwide claims database
Please note:
This action will also remove this member from your connections and send a report to the site admin.
Please allow a few minutes for this process to complete.